Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencySat, 18 May 2024 10:13:46 +0200Wed, 10 Jan 2024 15:45:00 +0100Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bavencioHuman medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/bavencioWed, 10 Jan 2024 15:45:00 +0100Human medicineBavencio : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500236648_en.pdfBavencio : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500236648_en.pdfFri, 13 Oct 2017 02:00:00 +0200Human medicine